Meuth, Sven |
| Recruiting | 2 | 50 | Europe | Bortezomib, Placebo, isotonic NaCl solution | Jena University Hospital | Autoimmune Encephalitis | 11/25 | 04/26 | | |
NCT05798520: A Study to Evaluate Safety and Efficacy of BIIB091 in Participants With Relapsing Forms of Multiple Sclerosis |
|
|
| Recruiting | 2 | 275 | Europe, US, RoW | BIIB091, DRF, Placebo | Biogen | Relapsing Forms of Multiple Sclerosis | 07/25 | 11/26 | | |
CIRMS, NCT05019248: Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine |
|
|
| Recruiting | N/A | 260 | Europe | Most recent vaccine to seasonal influenza | Heinrich-Heine University, Duesseldorf | Multiple Sclerosis, Relapsing-Remitting, Vaccine Response Impaired | 12/21 | 04/22 | | |
Pawlitzki, Marc |
| Recruiting | 2 | 136 | Europe | Autologous, tumor lysate-loaded, mature dendritic cells (DC), dendritic cell vaccination, standard therapy, temozolomide, fractionated radiochemotherapy | Heinrich-Heine University, Duesseldorf, German Federal Ministry of Education and Research | Glioblastoma | 11/26 | 03/27 | | |
| Recruiting | N/A | 20 | Europe | Increased multimodal observation including digital monitoring, Withings Scanwatch 2 | Heinrich-Heine University, Duesseldorf | Myasthenia Gravis, Myasthenic Syndrome, Lambert-Eaton Myasthenic Syndrome | 10/25 | 10/25 | | |
SAFEGUIDE-MS, NCT06461481: Strategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple Sclerosis |
|
|
| Recruiting | N/A | 150 | Europe | Withings Scanwatch | Heinrich-Heine University, Duesseldorf | Multiple Sclerosis | 10/26 | 12/26 | | |
EMDA CIDP, NCT05723848: Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy |
|
|
| Active, not recruiting | N/A | 46 | Europe | Smartwatch (Withings Scanwatch) | Heinrich-Heine University, Duesseldorf | CIDP | 07/24 | 07/24 | | |
SATURATE-MS, NCT05701423: A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) Participants |
|
|
| Active, not recruiting | N/A | 34 | Europe | Natalizumab, Tysabri | Biogen | Multiple Sclerosis | 07/24 | 07/24 | | |
Rolfes, Leoni |
CIRMS, NCT05019248: Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine |
|
|
| Recruiting | N/A | 260 | Europe | Most recent vaccine to seasonal influenza | Heinrich-Heine University, Duesseldorf | Multiple Sclerosis, Relapsing-Remitting, Vaccine Response Impaired | 12/21 | 04/22 | | |